Biohaven Appoints Bob Repella to Board of Directors

NEW HAVEN, Conn., Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE : BHVN ) today announced the appointment of Robert (Bob) Repella to its Board of Directors. Mr. Repella has extensive experien... Biopharmaceuticals, Neurology, Personnel Biohaven Pharmaceutical, CGRP receptor antagonist, glutamate modulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news